title: TSPO as a target for treatments of diseases, including neuropathological disorders.
authors.affiliation: Department of Neuroscience, Faculty of Medicine, Rappaport Family Institute for Research in the Medical Sciences, Technion - Israel Institute of Technology, Haifa, Israel.
authors.forename: L
authors.initials: L
authors.lastname: Veenman
authors.affiliation: Department of Neuroscience, Faculty of Medicine, Rappaport Family Institute for Research in the Medical Sciences, Technion - Israel Institute of Technology, Haifa, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Vainshtein
authors.affiliation: Department of Neuroscience, Faculty of Medicine, Rappaport Family Institute for Research in the Medical Sciences, Technion - Israel Institute of Technology, Haifa, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Gavish
mesh_terms: D000818:Animals; D018756:GABA Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000378:metabolism; D058990:Molecular Targeted Therapy; D018079:Receptors, GABA / Q000502:physiology*
chemical_list: D018756:GABA Antagonists; D018079:Receptors, GABA; C499229:TSPO protein, human